Testing effectiveness (Phase 2)Study completedNCT00107536
What this trial is testing
Lapatinib Ditosylate in Treating Patients With Unresectable Liver or Biliary Tract Cancer
Who this might be right for
Adult Primary Hepatocellular CarcinomaAdvanced Adult Primary Liver CancerLocalized Unresectable Adult Primary Liver Cancer+5 more
National Cancer Institute (NCI) 26